Literature DB >> 32667643

Methadone for Opioid Use Disorder-Decades of Effectiveness but Still Miles Away in the US.

Paul J Joudrey1, E Jennifer Edelman1, Emily A Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32667643      PMCID： PMC9020371          DOI： 10.1001/jamapsychiatry.2020.1511

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   25.911


× No keyword cloud information.
  7 in total

1.  Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment.

Authors:  Jeffrey H Samet; Michael Botticelli; Monica Bharel
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

2.  Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington.

Authors:  Solmaz Amiri; Robert Lutz; M Eugenia Socías; Michael G McDonell; John M Roll; Ofer Amram
Journal:  J Subst Abuse Treat       Date:  2018-07-24

3.  Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States.

Authors:  Paul J Joudrey; E Jennifer Edelman; Emily A Wang
Journal:  JAMA       Date:  2019-10-01       Impact factor: 56.272

4.  A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.

Authors:  Jamey J Lister; Addie Weaver; Jennifer D Ellis; Joseph A Himle; David M Ledgerwood
Journal:  Am J Drug Alcohol Abuse       Date:  2019-12-06       Impact factor: 3.829

Review 5.  Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction.

Authors:  S L Calcaterra; P Bach; A Chadi; N Chadi; S D Kimmel; K L Morford; P Roy; J H Samet
Journal:  J Gen Intern Med       Date:  2019-02-06       Impact factor: 5.128

6.  Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.

Authors:  Paul J Joudrey; Nicholas Chadi; Payel Roy; Kenneth L Morford; Paxton Bach; Simeon Kimmel; Emily A Wang; Susan L Calcaterra
Journal:  Drug Alcohol Depend       Date:  2020-03-27       Impact factor: 4.492

7.  Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US.

Authors:  Robert A Kleinman
Journal:  JAMA Psychiatry       Date:  2020-11-01       Impact factor: 21.596
  7 in total
  12 in total

1.  COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.

Authors:  Ximena A Levander; Jarratt D Pytell; Kenneth B Stoller; P Todd Korthuis; Geetanjali Chander
Journal:  Subst Abus       Date:  2021-10-19       Impact factor: 3.716

2.  Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders.

Authors:  Mukaila A Raji; Shivani Priyadarshni; Xiaoying Yu; Biai Digbeu; Yong-Fang Kuo
Journal:  Am J Med       Date:  2022-02-06       Impact factor: 5.928

3.  Comorbid Affective and Substance Use Disorders of Medicaid/Medicare Beneficiaries at an Opioid Treatment Program Serving Small Urban and Rural Communities.

Authors:  Jamey J Lister; Guijin Lee; Jennifer D Ellis; Emily Pasman; Elizabeth Agius; Stella M Resko
Journal:  Front Psychiatry       Date:  2022-05-02       Impact factor: 5.435

4.  The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic.

Authors:  Betty Tai; Ronald Dobbins; Quandra Blackeney; David Liu; Landhing Moran
Journal:  Addict Sci Clin Pract       Date:  2021-05-08

5.  Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.

Authors:  Paul J Joudrey; Gavin Bart; Robert K Brooner; Lawrence Brown; Julie Dickson-Gomez; Adam Gordon; Sarah S Kawasaki; Jane M Liebschutz; Edward Nunes; Dennis McCarty; Robert P Schwartz; José Szapocnik; Madhukar Trivedi; Judith I Tsui; Arthur Williams; Li-Tzy Wu; David A Fiellin
Journal:  Subst Abus       Date:  2021       Impact factor: 3.716

6.  Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.

Authors:  Ximena A Levander; Kim A Hoffman; John W McIlveen; Dennis McCarty; Javier Ponce Terashima; P Todd Korthuis
Journal:  Addict Sci Clin Pract       Date:  2021-12-11

7.  Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey.

Authors:  Sachini Bandara; Hannah Maniates; Eric Hulsey; Jennifer S Smith; Ellen DiDomenico; Elizabeth A Stuart; Brendan Saloner; Noa Krawczyk
Journal:  BMC Health Serv Res       Date:  2022-03-30       Impact factor: 2.655

8.  Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.

Authors:  Paul J Joudrey; Marynia Kolak; Qinyun Lin; Susan Paykin; Vidal Anguiano; Emily A Wang
Journal:  JAMA Netw Open       Date:  2022-04-01

9.  Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic.

Authors:  Michael Kidorf; Robert K Brooner; Kelly E Dunn; Jessica M Peirce
Journal:  J Subst Abuse Treat       Date:  2021-02-11

10.  Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.

Authors:  Paul J Joudrey; Zoe M Adams; Paxton Bach; Sarah Van Buren; Jessica A Chaiton; Lucy Ehrenfeld; Mary Elizabeth Guerra; Brynna Gleeson; Simeon D Kimmel; Ashley Medley; Wassim Mekideche; Maxime Paquet; Minhee Sung; Melinda Wang; R O Olivier You Kheang; Jingxian Zhang; Emily A Wang; E Jennifer Edelman
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.